SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-18-007535
Filing Date
2018-07-11
Accepted
2018-07-11 13:27:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 azrxs3a.htm S-3/A 70043
2 OPINION ON LEGALITY ex5-1.htm EX-5.1 25753
  Complete submission text file 0001654954-18-007535.txt   96852
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3/A | Act: 33 | File No.: 333-226065 | Film No.: 18948479
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1